The Value Added Tax (Drugs and Medicines) (Health and Welfare) Order 2026

Extended VAT zero-rating to medicines dispensed by pharmacy technicians and included Welsh legislation in the criteria for health-related VAT exemptions.


This Order modifies the Value Added Tax Act 1994 to extend zero-rating and exemptions to specific healthcare supplies and institutions.

It authorizes zero-rating for drugs and medicines dispensed by registered pharmacy technicians, or those under their supervision, provided they have pharmacist authorization.

Additionally, the Order expands the VAT exemption for state-regulated care institutions to include those regulated under a Measure or Act of Senedd Cymru, ensuring parity for Welsh regulatory frameworks.

Arguments For

  • The Order states that including regulations 220A and 220B of the Human Medicines Regulations 2012 ensures that prescriptions dispensed by registered pharmacy technicians under pharmacist authorization qualify for zero-rating.

  • Proponents argue that the amendment to Group 7 of Schedule 9 corrects a previous omission by including Measures or Acts of Senedd Cymru in the definition of state-regulated care.

  • The document indicates that these changes align VAT treatment for medicines and health services with updated regulatory frameworks for healthcare professionals and devolved legislative powers.

Arguments Against

  • Legal scholars might note that the zero-rating depends on the specific authorization of a pharmacist, which could create administrative burdens for pharmacies to document compliance.

  • Tax practitioners may point out that the delayed inclusion of Welsh legislation in the definition of state-regulated institutions suggests a period of regulatory inconsistency for care providers in Wales prior to this Order.

  • Affected parties might find the reliance on cross-references to the Human Medicines Regulations 2012 complex to navigate without updated guidance from HM Revenue and Customs.

1.—(1) This Order may be cited as the Value Added Tax (Drugs and Medicines) (Health and Welfare) Order 2026 and comes into force on 10th December 2026.

(2) Article 2 has effect in relation to supplies made on or after 10th December 2026.

  1. In Part 2 of Schedule 8 to the Value Added Tax Act 1994 (zero-rating), in Group 12 (drugs, medicines, aids for the disabled, etc), in Note (2D)(b), after paragraph (j) insert—

"(k) regulations 220A and 220B of the Human Medicines Regulations 2012(c).".

  1. In Part 2 of Schedule 9 to the Value Added Tax Act 1994 (exemptions), in Group 7 (health and welfare), in Note (8)(d), in the definition of "Act" after paragraph (b) insert—

"(ba) a Measure or Act of Senedd Cymru;".

Related

The Individual Savings Account (Amendment and Revocation) Regulations 2026

Thu 19th Nov 26

Mandated monthly reporting of ISA subscription events and standardized the procedures for annual tax repayment claims by account managers.

Read More

The Financial Services and Markets Act 2023 (Addition of Relevant Enactments) Regulations 2026

Thu 19th Nov 26

Expanded the list of laws that the Treasury can modify to facilitate financial technology testing in regulatory sandboxes.

Read More

The Social Security (Non-Benefit Payments) Regulations 2026

Wed 18th Nov 26

Designated Jobs Guarantee and Youth Jobs Grant payments as non-benefit payments to enable the recovery of overpayments and the prosecution of fraud.

Read More

The Value Added Tax (Distance Selling) (Amendments) Regulations 2026

Wed 18th Nov 26

Updated VAT accounting and refund rules for Northern Ireland distance selling under the One Stop Shop and Import One Stop Shop schemes.

Read More